Mark Malkin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Mark Malkin

Showing results (11-20 of 12) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 12 results.

Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasMomina Qureshi, David Peereboom, Emily Zabor, et al.

European Journal of Cancer (Oxford, England : 1990)|May 22, 2012

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modalityRoger Stupp, Eric T Wong, Andrew A Kanner, et al.

Pageof 2

Search research articles

Showing results (11-20 of 12) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 12 results.

Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasMomina Qureshi, David Peereboom, Emily Zabor, et al.

European Journal of Cancer (Oxford, England : 1990)|May 22, 2012

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modalityRoger Stupp, Eric T Wong, Andrew A Kanner, et al.

Pageof 2